Sherry Korczynski - 14 Aug 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Commercial Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
14 Aug 2025
Net transactions value
$0
Form type
4
Filing time
15 Aug 2025, 08:41:12 UTC
Previous filing
10 Jun 2025
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Korczynski Sherry Chief Commercial Officer C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 15 Aug 2025 0002026090

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Award $0 +25,000 +16% $0.000000 181,858 14 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.